Cognitive-Behavioral Therapy for Sleep Disturbance in Patients Undergoing Peritoneal Dialysis: A Pilot Randomized Controlled Trial
Background
Greater than 50% of dialysis patients experience sleep disturbances. Cognitive-behavioral therapy (CBT) is effective for treating chronic insomnia, but its effectiveness has never been reported in peritoneal dialysis (PD) patients and its association with cytokines is unknown. We investigated the effectiveness of CBT in PD patients by assessing changes in sleep quality and inflammatory cytokines.
Study Design
Randomized control study with parallel-group design.
Setting & Participants
24 PD patients with insomnia in a tertiary medical center without active medical and psychiatric illness were enrolled.
Intervention
The intervention group (N = 13) received CBT from a psychiatrist for 4 weeks and sleep hygiene education, whereas the control group (N = 11) received only sleep hygiene education.
Outcomes & Measurements
Primary outcomes were changes in the Pittsburgh Sleep Quality Index and Fatigue Severity Scale scores, and secondary outcomes were changes in serum interleukin 6 (IL-6), IL-1β, IL-18, and tumor necrosis factor α levels during the 4-week trial.
Results
Median percentages of change in global Pittsburgh Sleep Quality Index scores were −14.3 (interquartile range, −35.7 to − 6.3) and −1.7 (interquartile range, −7.6 to 7.8) in the intervention and control groups, respectively (P = 0.3). Median percentages of change in global Fatigue Severity Scale scores were −12.1 (interquartile range, −59.8 to −1.5) and −10.5 (interquartile range, −14.3 to 30.4) in the intervention and control groups, respectively (P = 0.04). Serum IL-1β level decreased in the intervention group, but increased in the control group (P = 0.04). There were no significant differences in changes in other cytokines.
Limitations
This study had a small number of participants and short observation period, and some participants concurrently used hypnotics.
Conclusions
CBT may be effective for improving the quality of sleep and decreasing fatigue and inflammatory cytokine levels. CBT can be an effective nonpharmacological therapy for PD patients with sleep disturbances.
Index Words: Cognitive-behavioral therapy, insomnia, interleukin 1β, interleukin 18, tumor necrosis factor α
To access this article, please choose from the options below
Originally published online as doi:10.1053/j.ajkd.2008.03.012 on May 23, 2008.Trial registration: http://clinicaltrials.gov; study number: NCT00155441.
PII: S0272-6386(08)00590-8
doi:10.1053/j.ajkd.2008.03.012
© 2008 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
